↓ Skip to main content

Dove Medical Press

Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective

Overview of attention for article published in Drug Design, Development and Therapy, December 2010
Altmetric Badge

Mentioned by

wikipedia
3 Wikipedia pages

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
203 Mendeley
citeulike
2 CiteULike
Title
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective
Published in
Drug Design, Development and Therapy, December 2010
DOI 10.2147/dddt.s10812
Pubmed ID
Authors

Richard Kones

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 203 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 2%
Brazil 2 <1%
United Kingdom 1 <1%
New Zealand 1 <1%
Canada 1 <1%
Unknown 194 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 32 16%
Student > Ph. D. Student 25 12%
Student > Bachelor 24 12%
Researcher 20 10%
Other 11 5%
Other 47 23%
Unknown 44 22%
Readers by discipline Count As %
Medicine and Dentistry 67 33%
Agricultural and Biological Sciences 18 9%
Nursing and Health Professions 13 6%
Biochemistry, Genetics and Molecular Biology 10 5%
Social Sciences 7 3%
Other 28 14%
Unknown 60 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 May 2018.
All research outputs
#8,616,072
of 25,576,801 outputs
Outputs from Drug Design, Development and Therapy
#646
of 2,254 outputs
Outputs of similar age
#57,968
of 191,750 outputs
Outputs of similar age from Drug Design, Development and Therapy
#5
of 7 outputs
Altmetric has tracked 25,576,801 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,254 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,750 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.